catechol has been researched along with Idiopathic Parkinson Disease in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A full understanding of Parkinson's Disease etiopathogenesis and of the causes of the preferential vulnerability of nigrostriatal dopaminergic neurons is still an unsolved puzzle." | 2.61 | Impaired dopamine metabolism in Parkinson's disease pathogenesis. ( Boassa, D; Bubacco, L; Masato, A; Plotegher, N, 2019) |
| "Although the cause of Parkinson's disease is unknown, oxidative stress has been implicated in its pathogenesis." | 2.40 | [Oxidative stress and the brain]. ( Tanaka, M, 1997) |
| "Pakinson diseases, schizophrenia, and breast cancer." | 1.43 | [The relationship between catechol O-methyltransferase and diseases]. ( Bi, XL; Dou, TY; Ge, GB; Hou, J; Ma, H; Qian, XK; Xia, YL; Yang, L, 2016) |
| "Pure autonomic failure (PAF) and Parkinson's disease (PD) share several clinical laboratory abnormalities; however, PAF is not associated with parkinsonism." | 1.35 | Central dopamine deficiency in pure autonomic failure. ( Bernson, M; Carmona, G; Goldstein, DS; Holmes, C; Imrich, R; Mizrahi, N; Sato, T; Sharabi, Y; Vortmeyer, AO, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chavarria, D | 1 |
| Benfeito, S | 1 |
| Soares, P | 1 |
| Lima, C | 1 |
| Garrido, J | 1 |
| Serrão, P | 1 |
| Soares-da-Silva, P | 1 |
| Remião, F | 1 |
| Oliveira, PJ | 1 |
| Borges, F | 1 |
| Masato, A | 1 |
| Plotegher, N | 1 |
| Boassa, D | 1 |
| Bubacco, L | 1 |
| Goldstein, DS | 2 |
| Qian, XK | 1 |
| Xia, YL | 1 |
| Dou, TY | 1 |
| Hou, J | 1 |
| Ma, H | 1 |
| Ge, GB | 1 |
| Yang, L | 1 |
| Bi, XL | 1 |
| Feng, JH | 1 |
| Hu, XL | 1 |
| Lv, XY | 1 |
| Wang, BL | 1 |
| Lin, J | 1 |
| Zhang, XQ | 1 |
| Ye, WC | 1 |
| Xiong, F | 1 |
| Wang, H | 1 |
| Soloway, AH | 1 |
| Soloway, PD | 1 |
| Warner, VD | 1 |
| Contu, VR | 1 |
| Kotake, Y | 1 |
| Toyama, T | 1 |
| Okuda, K | 1 |
| Miyara, M | 1 |
| Sakamoto, S | 1 |
| Samizo, S | 1 |
| Sanoh, S | 1 |
| Kumagai, Y | 1 |
| Ohta, S | 1 |
| Dell'Acqua, S | 1 |
| Pirota, V | 1 |
| Anzani, C | 1 |
| Rocco, MM | 1 |
| Nicolis, S | 1 |
| Valensin, D | 1 |
| Monzani, E | 1 |
| Casella, L | 1 |
| Kimos, M | 1 |
| Burton, M | 1 |
| Urbain, D | 1 |
| Caudron, D | 1 |
| Martini, M | 1 |
| Famelart, M | 1 |
| Gillard, M | 1 |
| Barrow, J | 1 |
| Wood, M | 1 |
| Mazzulli, JR | 1 |
| Burbulla, LF | 1 |
| Krainc, D | 1 |
| Ischiropoulos, H | 1 |
| Stern, G | 1 |
| Subramaniam, V | 1 |
| Griffith, L | 1 |
| Haes, AJ | 1 |
| Hasegawa, T | 1 |
| Matsuzaki-Kobayashi, M | 1 |
| Takeda, A | 1 |
| Sugeno, N | 1 |
| Kikuchi, A | 1 |
| Furukawa, K | 1 |
| Perry, G | 1 |
| Smith, MA | 1 |
| Itoyama, Y | 1 |
| Holmes, C | 1 |
| Sato, T | 1 |
| Bernson, M | 1 |
| Mizrahi, N | 1 |
| Imrich, R | 1 |
| Carmona, G | 1 |
| Sharabi, Y | 1 |
| Vortmeyer, AO | 1 |
| Tanaka, M | 1 |
4 reviews available for catechol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Impaired dopamine metabolism in Parkinson's disease pathogenesis.
Topics: Animals; Brain; Catechols; Dopamine; Dopaminergic Neurons; Humans; Oxidative Stress; Parkinson Disea | 2019 |
The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.
Topics: Aldehyde Dehydrogenase; Aldehydes; alpha-Synuclein; Animals; Catechols; Dopamine; Humans; Monoamine | 2021 |
Why catechol?
Topics: Animals; Catechols; History, 19th Century; History, 20th Century; Humans; Parkinson Disease | 2011 |
[Oxidative stress and the brain].
Topics: Animals; Catechols; Dopamine; Ferritins; Humans; Iron; Lipid Peroxidation; Microglia; Oxidative Stre | 1997 |
11 other studies available for catechol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Boosting caffeic acid performance as antioxidant and monoamine oxidase B/catechol-O-methyltransferase inhibitor.
Topics: Amides; Antioxidants; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catecho | 2022 |
[The relationship between catechol O-methyltransferase and diseases].
Topics: Breast Neoplasms; Catechol O-Methyltransferase; Catechols; Dopamine; Epinephrine; Estradiol; Humans; | 2016 |
Synthesis and biological evaluation of clovamide analogues with catechol functionality as potent Parkinson's disease agents in vitro and in vivo.
Topics: Apoptosis; Catechols; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Molecular Structur | 2019 |
Possible chemical initiators of cognitive dysfunction in phenylketonuria, Parkinson's disease and Alzheimer's disease.
Topics: Alzheimer Disease; Catechols; Cognition Disorders; Humans; Metabolic Networks and Pathways; Methioni | 2013 |
Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Topics: Animals; Blotting, Western; Catechols; Cell Line, Tumor; Cell Survival; Dopamine; Electrophoresis, A | 2014 |
Reactivity of copper-α-synuclein peptide complexes relevant to Parkinson's disease.
Topics: alpha-Synuclein; Amino Acid Sequence; Catechols; Copper; Humans; Molecular Sequence Data; Oxidation- | 2015 |
Development of an HTRF Assay for the Detection and Characterization of Inhibitors of Catechol-O-Methyltransferase.
Topics: Benzophenones; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Hig | 2016 |
Detection of Free and Protein-Bound ortho-Quinones by Near-Infrared Fluorescence.
Topics: Catechols; Dopamine; Dopaminergic Neurons; Fluorescence; Humans; Induced Pluripotent Stem Cells; Inf | 2016 |
Varying nanoparticle pseudostationary phase plug length during capillary electrophoresis.
Topics: Catechols; Dopamine; Electrophoresis, Capillary; Epinephrine; Fatty Acids; Humans; Levodopa; Nanopar | 2011 |
Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease.
Topics: alpha-Synuclein; Apoptosis; Catechols; Cells, Cultured; Comet Assay; DNA Damage; Enzyme Activation; | 2006 |
Central dopamine deficiency in pure autonomic failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Autonomic Nervous System Diseases; Brain; Catechols; Dihydroxy | 2008 |